Non-clinical assessment of the carcinogenic potential of human insulin analogues - Scientific guideline
HumanScientific guidelines
On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.
This document provides guidance on the general approach to the assessment of potential mitogenicity and carcinogenicity of new insulin analogues.
Keywords: Insulin analogues, carcinogenic potential, mitogenic potential, in vitro assays, in vivo assays